Concepedia

Elisabeth V. Schneider

EV

9

Publications

983

Citations

9

H-Index

1993

Active since

Affiliations

Max Planck Institute of Biochemistry(Current)

Technical University of Munich

University of Duisburg-Essen

University of Regensburg

Cardiff University

Elisabeth V. Schneider is an author at Max Planck Institute of Biochemistry specializing in medicine, cell biology, and cell signaling.

Top concepts

MedicineCell BiologyPharmacologyCell SignalingSignal TransductionDrug DiscoveryMedicinal ChemistryHealthAllergyObesity

Publications per year

1993–2020

9

Publications

9

Mediator kinase inhibition further activates super-enhancer-associated genes in AML

Henry E. Pelish, Brian B. Liau, I Niţulescu et al. · Nature · 2015 · 391 citations · Full text

Mediator Kinase Inhibition, Transcriptional Regulation, Signal Transduction +5

The Structure of CDK8/CycC Implicates Specificity in the CDK/Cyclin Family and Reveals Interaction with a Deep Pocket Binder

Elisabeth V. Schneider, Jark Böttcher, M. Blaesse et al. · Journal of Molecular Biology · 2011 · 142 citations · Full text

Structure–kinetic relationship study of CDK8/CycC specific compounds

Elisabeth V. Schneider, Jark Böttcher, Robert Huber et al. · Proceedings of the National Academy of Sciences · 2013 · 133 citations · Full text

Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells

Michael F. T. Koehler, Philippe Bergeron, Elizabeth M. Blackwood et al. · ACS Medicinal Chemistry Letters · 2016 · 84 citations · Full text

Chemoprevention Strategy, Cdk8 Kinase Activity, Pharmaceutical Chemistry +16

A precisely positioned MED12 activation helix stimulates CDK8 kinase activity

Felix Klatt, Alexander Leitner, Iana V. Kim et al. · Proceedings of the National Academy of Sciences · 2020 · 73 citations · Full text

Rows per page

1–5 of 9